You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials

Article metrics

Article menu

This article has a correction. Please see:

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Short report
Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials

 

Online download statistics by month:

Online download statistics by month: January 2020 to June 2025

AbstractFullPdf
Jan 202015815832
Feb 2020436436126
Mar 202015915942
Apr 2020707017
May 2020797946
Jun 2020606030
Jul 2020424217
Aug 2020414118
Sep 2020696924
Oct 2020525214
Nov 2020949454
Dec 2020999947
Jan 202113813867
Feb 202110610647
Mar 202111111147
Apr 2021999946
May 2021545431
Jun 2021686828
Jul 2021565631
Aug 2021505036
Sep 2021959556
Oct 2021909075
Nov 2021868657
Dec 2021595936
Jan 2022808842
Feb 2022787952
Mar 202211612884
Apr 202212313151
May 20229810068
Jun 2022707127
Jul 2022879050
Aug 2022777938
Sep 2022767938
Oct 2022939561
Nov 2022929555
Dec 2022747630
Jan 2023626236
Feb 2023828234
Mar 2023939944
Apr 2023616238
May 2023707136
Jun 2023596321
Jul 2023545430
Aug 2023576032
Sep 2023838342
Oct 2023686834
Nov 2023656526
Dec 2023737352
Jan 2024444726
Feb 2024565631
Mar 2024393989
Apr 2024515244
May 2024444444
Jun 2024444435
Jul 2024545636
Aug 2024363622
Sep 2024363624
Oct 2024747540
Nov 2024525417
Dec 2024727227
Jan 2025848433
Feb 2025858662
Mar 2025828344
Apr 202512212253
May 2025747673
Jun 2025464613
Total535754322758